Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC

Title
Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC
Authors
Keywords
Colorectal cancer, Peritoneal carcinomatosis, Mitomycin C, Oxaliplatin, HIPEC
Journal
EJSO
Volume 44, Issue 2, Pages 220-227
Publisher
Elsevier BV
Online
2017-11-17
DOI
10.1016/j.ejso.2017.10.216

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started